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Short Communication
Antigenic expression of heat-stable and heat-labile binding
sites on carcinoembryonic antigen
P.A. Keep, A.R. Gibbons & G.T. Rogers
Department ofMedical Oncology, Charing Cross Hospital, London W6 8RF, UK.
The use of heat treatment for the removal of non-
specific effects in the direct radioimmunoassay of
human circulatory CEA has been widely adopted
(Kim et al., 1979; Warner et al., 1973). However,
recent studies (Keep & Rogers, 1979; Rogers &
Keep, 1980) have shown the existence of heat-labile
determinants on CEA which may be destroyed by
this assay technique. Heat-labile antigens appeared
to be shared between CEA isolated from tumour
and normal colon whilst the heat-stable antigens
appeared to be more tumour-associated (Rogers &
Keep, 1980). The possibility was raised that
antisera against heat-treated CEA might be more
specific for a restricted population of CEA and
possibly for cancer detection. In the present
communication we report on the antigenic
expression and molecular distribution of heat-labile
and heat-stable epitopes on CEA.
Four rabbit antisera (241-244) and a goat
antiserum have been raised to heat-treated CEA
(CEA heated at 85°C for 30min in phosphate
buffer at pH5) and absorbed (Rogers & Keep,
1980). These antisera gave single lines of identity on
immunodiffusion against purified CEA with a
reference antiserum (G61) and did not cross-react
with NCA. They differ from our conventional
antisera 227 and PK1G in the extent to which they
recognise heat-labile components of CEA. This has
been shown for antiserum 241 by double antibody
radioimmunoassay (241 assay) before and after heat
treatment.
In separate experiments using different tumour
CEA preparations, 73 and 75% of the assayable
CEA were retained after heating. This contrasted
with results obtained using the two conventional
assays and also the Abbott EIA kit. In these cases
the assay values fell by 85%, 78% and 85%
respectively. Similar results were obtained for CEA
extracted from normal colon. In this experiment
CEA was prepared from four separate specimens
(Rogers & Keep, 1980), aliquots of each heat
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treated as described above and doubling dilutions
assayed. Using the 241 assay no significant change
in the CEA activity occurred after heat treatment.
Again this contrasted with the results of a
conventional assay (227) where 65% of the activity
was lost on heating. These experiments showed that
antiserum 241 reacted only very weakly with heat-
labile CEA as expected. Antisera to heat-treated
CEA also reacted very weakly with CEA prepared
from normal colon. This has previously been
demonstrated with antiserum 241 by rocket electro-
phoresis (Rogers & Keep, 1980) and has now been
confirmed by this technique with the additional
antisera raised to heat-treated CEA (Figure 1).
Whereas conventional anti-CEA (PK1G) produced
rockets with perchloric acid extracts of normal
colon at lmgml-l (120-200ng of CEAmg-1 of
extract), antisera to heat-treated CEA failed to
react at concentrations of extract up to 20mgml-1.
These results suggest that CEA in normal colon
may express an exceptionally high concentration of
heat-labile binding sites which are not detected by
antisera to heat-treated CEA.
Two approaches have been employed to ascertain
whether these specificity differences can be
attributed to different CEA populations. In an
inhibition experiment, described in Figure 2, the
presence of a conventional antiserum PK1G did not
block the binding of antibody 241 to radiolabelled
CEA. This indicated that these antibodies react
with unrelated binding sites. In addition, the
maximum binding of CEA label to both antibodies
was 56% at the greatest concentration of antibody
241 only dropping to 46% at the lowest concen-
tration showing that the majority of CEA molecules
expressed both binding sites. A residual population
of CEA, - 10%, appeared to express only 241-
binding sites.
These results have been confirmed by an affinity
chromatography method. Radiolabelled CEA,
applied to a column of 241-Sepharose, was used to
prepare 241-binding CEA. This was then applied to
a column of PKIG-Sepharose and the proportion
of bound and non-binding CEA estimated. Eighty-
four percent of the 241-binding CEA recovered was
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Figure 1 (A) Rocket electrophoresis in 1% agarose gel containing absorbed antiserum PKlG (1.5%). CEA
isolated from colon tumour (in wells d and g) show a single rocket which is immunologically identical to that
given by CEA isolated from normal colon tissue (well f). After heat-treatment of normal colon CEA (well e)
no detectable reaction was observed.
(B) Rocket electrophoresis in 1% agarose gel containing the absorbed goat antiserum against heat-treated
CEA (1%) demonstrating a single rocket with tumour CEA (well 2) and failure to react with CEA isolated
from normal colon (well 1).
(C) Repeat of experiment (B) but with agarose gel containing absorbed rabbit antiserum 241 against heat-
treated CEA (1%). Similar results were obtained with gels containing antisera 242-244.
capable of binding to the PKlG-Sepharose showing
that most of the CEA expressed both binding sites
on the same molecule.
Concanavalin A (Con A) binding of CEA
remained essentially unchanged after heating (Table
I). The structure of the heat-labile binding sites on
CEA is therefore unlikely to involve the
intermediate branched mannose. The proportion of
Con A non-binding CEA was much greater in the
case of CEA immunopurified from normal colon
but again heat treatment had no effect. Whether
the diminished Con A binding of normal colon
CEA is linked to the expression of high concen-
trations of heat-labile antibody binding sites on
normal colon CEA is unknown. However it can be
speculated that the arrangement and degree of
branching of the mannose chains (Con A binding)
in CEA may determine the heat lability of
dominant binding sites which are situated in the
protein moiety (see Rogers, 1976). It is of interest
in this context that the presence of human serum
during the heat treatment stage abolished theHEAT-LABILE EPITOPES ON CEA 955
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Figure 2 Attempted blocking of the binding of
antibody 241 by PK1G. Two-fold dilutions of rabbit
antibody 241 in 1:200 normal rabbit serum were made
over the range 1:200 to 1:25600. A titration of 241
(0) was then carried out by incubating 50jIl of each
dilution at 37°C for 16h with 50 p1 of 1251-CEA and
200pI of 0.1M phosphate buffer pH7. For the
competitive blocking (0) 50p1 of goat PK1G diluted
1:440 was added at each point of the titration instead
of 50p1 of buffer. An additional titration (El) included
both PK1G and its precipitating antibody horse anti-
goat. A titration in which the PK1G was replaced by
normal goat serum (1:440) was used as a control (x).
After incubation the 241-bound counts were
precipitated with 50p1 of sheep anti-rabbit antiserum
known not to cross-react with the goat antiserum and
50pl of 10% polyethylene glycol. After 3h at 20°C the
precipitates were filtered and the isotope counted. No
blocking of the binding of antiserum 241 by PK1G
occurred in this experiment.
decrease in subsequent assay value (Keep & Rogers,
1979). A similar masking effect was also implicated
in an assay of serum samples from patients with
colorectal cancer (Kim et al., 1979). It is likely that
components in serum, which have been shown to
bind to CEA, such as IgG and IgM (Harvey et al.,
1978; Pompecki, 1979; Pressman et al., 1979), may
confer heat stability on otherwise heat-labile
determinants.
In conclusion this study has confirmed our earlier
work showing that conventional anti-CEA antisera
can recognise heat-labile as well as heat-stable
binding sites on CEA. We have now provided
evidence that, although these sites are immuno-
P logically distinct, they are present on the same
molecular species of CEA thus ruling out the
possibility of a major subset of CEA with greater
cancer specificity. The results suggest that heat
stability of CEA antigens may depend on some
form of protection of the binding sites by an
appropriate configuration of the oligosaccharide
chains and this can be mimicked by components in
human serum. Antisera raised to heat-treated CEA
recognise mainly the heat-stable determinant. We
are currently producing monoclonal antibodies
against heat-treated CEA as this may lead to
further information on the importance of heat-
stable epitopes with respect to tumour specificity
and detection.
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Table I Effect of heat-treatment on the binding of CEA to Concanavalin A-
Sepharose (Con A).
Source ofCEA Non-binding (%) Bound (%) Recovery (%)
Tumour 6 93 51
Tumour (heated) 16 84 60
Normal colon 63 36 57
Normal colon (heated) 67 32 100
Purified tumour-derived CEA (1420yg by assay) was applied to a column of
Con A-Sepharose and the CEA assayed (PKIG assay) in the non-binding
fraction and the bound fraction eluted with 20% methyl glucoside. The same
amount of CEA was heat-treated (assay value after heating - 620pg) and
again the CEA determined in the Con A non-binding and bound fractions.
The experiment was repeated with CEA isolated from normal colon (3.17/.Ig
before heating and 0.53jig after heating). All column fractions were dialysed
against 0.1 M phosphate buffer, pH7, before assay. Results were expressed as a
percentage of the CEA recovered from the affinity column.
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